Search

Your search keyword '"Triest, B."' showing total 266 results

Search Constraints

Start Over You searched for: Author "Triest, B." Remove constraint Author: "Triest, B." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
266 results on '"Triest, B."'

Search Results

1. Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma.

2. A Phase I Study of the DNA-PK Inhibitor Peposertib in Combination with Radiotherapy with or without Cisplatin in Patients with Advanced Head and Neck Tumors

4. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

6. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

8. Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study

11. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

12. PD-0798 Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac

13. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study

14. Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non-Small Cell Lung Cancer

16. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

17. First system for fully-automated multi-criterial treatment planning for a high-magnetic field MR-Linac applied to rectal cancer

20. PD-0071: The MOMENTUM study, an international registry of patients treated on an MR-linac: 9-month experience

25. The Patterns of Care, Tolerability and Safety in the First Year of a Novel High Field MR-Linac

26. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

27. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

29. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

30. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

35. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

38. Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials

39. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

40. Radiotherapy quality assurance program for the STAR-TReC trial; planning results of Dutch centers

41. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

44. OC-0608: Radiotherapy quality assurance program for the STAR-TReC trial; planning results of Dutch centers

Catalog

Books, media, physical & digital resources